Market Research Blog

The pharmaceutical drug delivery market trends was worth US$ 1600 billion in 2021 and is predicted to grow to US$ 3000 billion by 2032, a CAGR of 6% during the forecast period.

“The growing incidence of infectious diseases globally, expanding R&D expenditure for innovative medicines, and rising FDA approvals all contribute to the expansion of this market category.”

The increased prevalence of chronic diseases, the developing biologics industry, extensive R&D investments, and technological innovations & new product launches are all contributing to the rise in the pharmaceutical drug delivery industry.

Pharmaceutical drug delivery device has certain advantages, including ease of use, efficiency, and patient compliance. As a result, drug developers are concentrating on appropriate delivery and packaging alternatives to increase treatment efficiency and provide enhanced patient compliance.

The pharmaceutical drug delivery market trends and forecast indicate that the businesses are investing heavily in research and development to create new compounds for various therapeutic applications and drug delivery platforms. The corporations put a lot of money into R&D to bring high-quality, innovative items to market. Biopharmaceutical businesses’ R&D spending has likewise increased over time.

For pharmaceutical drug delivery carriers, self-administration and home care are likely to provide considerable growth prospects. This is primarily due to the growing geriatric population, as elderly people make up a sizable market for drug delivery devices for home care. This aspect is also driving up demand for application-specific injectable, inhalation, topical, and transdermal medication treatments tailored to caregivers’ and patients’ needs.

Governments in both rich and developing countries advocate cost-cutting pharmaceutical drug delivery mechanisms like lowering prescription reimbursement prices and boosting the use of generics. Government agencies, insurers, and patients are putting pressure on drug makers all across the world to cut costs. The global market study on the pharmaceutical drug delivery market indicates that due to the downward pricing pressure, drug acceptance is increasing in emerging markets, where the need for low-cost treatments is high.

Several pharmaceutical companies, however, are suffering as a result of this. Moreover, this trend is projected to continue in the next years, owing to ongoing demand from insurers, pharmacy benefit managers (PBMs), and public and private payers to lower pharmaceutical drug delivery device pricing to cover more innovative drugs for common ailments like high cholesterol and diabetes.

The pharmaceutical drug delivery market share is projected to reach US$ 2200 Bn by 2026.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-14307

Key Takeaways

• The high share of the North American market can be attributed to the rising prevalence of chronic diseases like cancer, respiratory allergies, and diabetes, as well as increasing patient compliance with innovative drug delivery technologies and the presence of a large number of major players in the region.
• Infectious disorders accounted for the greatest portion of the pharmaceutical drug delivery industry in 2020.
• The rising prevalence of infectious diseases around the world, rising R&D expenditure for new treatments as a result of the present COVID-19 pandemic scenario, and the rising number of FDA approvals for such drugs all contribute to the infectious disorder market segment’s substantial share.
• Governments in developing nations are investing heavily in modernizing their healthcare infrastructure, which is projected to enhance access to healthcare services.

“The increased prevalence of chronic diseases, the developing biologics industry, and increasing technological breakthroughs and new product releases are all driving this market forward.”—opines an FMI analyst.

Competitive Landscape 

The number of pharmaceutical drug delivery carriers is growing due to increased spending by key market players in research and development and clinical trials of pharmaceutical medication delivery methods.

Due to multiple major, medium, and small players, the worldwide pharmaceutical drug delivery market is extremely competitive and fragmented. These companies have a significant market share in their respective regions. Leading players’ growth strategies are expected to propel the global market as per the upcoming pharmaceutical drug delivery market key trends & opportunities.

• DARZALEX (daratumumab), a subcutaneous formulation that decreases treatment time for multiple myeloma indications, was approved by the FDA in July 2021.
• Pfizer, Inc. gained FDA approval in December 2020 for BRAFTOVI (encorafenib) plus cetuximab to manage patients with brafv600e-mutant metastatic colorectal cancer (CRC) who have previously received treatment.

Key Segments

By Route of Administration:

• Oral Drug Delivery
• Injectable Drug Delivery
• Topical Drug Delivery
• Ocular Drug Delivery
• Pulmonary Drug Delivery
• Nasal Drug Delivery
• Transmucosal Drug Delivery
• Implantable Drug Delivery

By Application:

• Infectious Diseases
• Cancer
• Cardiovascular Diseases
• Diabetes
• Respiratory Diseases
• Central Nervous System Disorders
• Autoimmune Diseases
• Other Applications

By Facility of Use:

• Hospitals
• Ambulatory Surgery Centers/Clinics
• Home Care Settings
• Diagnostic Centers
• Other Facilities of Use

By Region:

• North America
• Latin America
• Europe
• Europe
• Asia Pacific
• Middle East and Africa (MEA)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-14307

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Summary of Statistics

1.3. Key Market Characteristics & Attributes

1.4. Fact.MR Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

3.1. Risk Assessment

3.1.1. COVID-19 Crisis and Impact on Pharmaceutical Drug Delivery Demand

3.1.2. COVID-19 Impact Benchmark with Previous Crisis

3.1.3. Impact on Market Value (US$ Mn)

3.1.4. Assessment by Key Countries

3.1.5. Assessment by Key Market Segments

3.1.6. Action Points and Recommendation for Suppliers

3.2. Key Trends Impacting the Market

3.3. Formulation and Product Development Trends

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-14307

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

As per the gastrointestinal stent market growth survey by Future Market Insights (FMI), the market is poised to attain a CAGR of 6% during the forecast period, i.e., 2022-2032.

The rising preference for minimally invasive (MI) surgical procedures is having a significant impact on the gastrointestinal stent market growth as in comparison to traditional open surgery procedures; stenting has a lower risk of gastrointestinal infection, less blood loss, and a shorter recovery period.

As per gastrointestinal stents market study, gastrointestinal stents market future trends are likely to be swayed by various technological advancements, such as the development of gastrointestinal biodegradable stents and nitinol material-based stents with a high degree of flexibility and kink-resistance can be considered as some of the major emerging trends in gastrointestinal stent market.

Ongoing research and development activities in the business sector are also expected to sway the gastrointestinal stents adoption trends during the forecast period. For example, Brigham and Women’s Hospital and MIT researchers announced the development of a stretchable stent with pop-out needles for use in drug delivery in gastrointestinal systems and other tubular organs.

Sales of gastrointestinal stents are likely to surge owing to significant growth in healthcare infrastructure, favorable government policies, and extensive research and development (R&D) activities.

In most Asian countries, government reimbursement for endoscopic stenting procedures is limited or non-existent, one of the major reasons for patient and physician reluctance to use gastrointestinal stents, narrowing down the gastrointestinal stents market outlook.

Such a high cost and a lack of reimbursement in developing countries such as India are expected to limit patient adoption of gastrointestinal stent-related procedures.

Taking into account the factors mentioned above, the gastrointestinal market size is projected to reach US$ 600 Mn by 2026.

Key Takeaways:

• Due to the increasing prevalence of chronic liver disease and the increase in the number of surgical procedures for the treatment of biliary diseases, the biliary stents segment is likely to account for the largest gastrointestinal stents market share as per the product type.
• Based on material, self-expanding metal stents are expected to lead the market. The same can be credited to benefits such as ease of insertion, a lower possibility of dislodgment or migration, and longer patency.
• During the forecast period, the gastrointestinal cancers segment is anticipated to have the highest CAGR attributed to the increased prevalence and incidence, thereby positively impacting the gastrointestinal stents market trends.
• The hospitals and clinics segment will be at the forefront of the market, owing to many endoscopic retrograde cholangiopancreatographies (ERCP) and percutaneous transhepatic cholangiography (PTC) procedures performed in hospitals for various disease indications.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-14295

“In terms of market share and revenue, North America is predicted to dominate the gastrointestinal/GI stent market and will maintain its dominance throughout the forecast period on account of a sophisticated level of healthcare facilities, a rising geriatric population, high incidence of gastrointestinal diseases, favorable reimbursement scenario, and presence of key market players such as C.R. Bard (US), and Becton, Boston Scientific Corporation (US), Dickinson and Company.” opines an FMI researcher.

Competitive Landscape:Among the prominent players in the GI, stents market are Merit Medical Systems (US), Cantel Medical (US), Olympus Corporation (Japan), CONMED Corporation (US), Taewoong Medical (South Korea), Endo-Flex GmbH (Germany), Micro-Tech (Nanjing) Co., Ltd. (China), MI-Tech (South Korea), QualiMed (Germany), UK Medical (UK), Hobbs Medical Inc. (US), CITEC (China), BCM Corporation (South Korea), Leufen Medical GmbH (Germany) and Medorah Meditek Pvt. Ltd. (India).

The gastrointestinal stent market is moderately competitive, with numerous gastrointestinal stents market opportunities. In addition, the increasing prevalence of diseases associated with gastrointestinal tract stent placement is driving up demand for gastrointestinal stents.

As a result, several global corporations are implementing various strategies to reach out to emerging economies such as product launches, mergers, acquisitions, partnerships, collaborations, etc.

Some of the recent developments in the gastrointestinal stents market are:

• Cook Medical worked with Taewoong Medical to expand patient treatment options by distributing a variety of Taewoong’s stents in the United States. The Niti-STM Through the Scope (TTS) Esophageal Stent, the flagship product of the South Korean company’s Niti-S Self-Expandable line of the metal gastrointestinal stent, is included in this distribution collaboration.
• Olympus has proposed a couple of self-expanding metal stents (SEMS) to be used as palliative measures in patients with a short life expectancy or who have malignant colonic or duodenal obstruction.

Key Segments

By Product:

• Biliary Stents
• Duodenal Stents
• Colonic Stents
• Pancreatic Stents
• Esophageal Stents

By Material:

• Self-Expanding Metal Stents
• Plastic Stents

By Application:

• Biliary Diseases
• Irritable Bowel Syndrome
• Gastrointestinal Cancers
• Colorectal Cancer
• Stomach Cancer
• Esophageal Cancer
• Pancreatic Cancer

By End User:

• Hospitals And Clinics
• Ambulatory Surgical Centers

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-14295

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Summary of Statistics

1.3. Key Market Characteristics & Attributes

1.4. Fact.MR Analysis and Recommendations

2. Market Overview

2.1. Market Coverage

2.2. Market Definition

3. Market Risks and Trends Assessment

3.1. Risk Assessment

3.1.1. COVID-19 Crisis and Impact on Gastrointestinal Stent

3.1.2. COVID-19 Impact Benchmark with Previous Crisis

3.1.3. Impact on Market Value (US$ Mn)

3.1.4. Assessment by Key Countries

3.1.5. Assessment by Key Market Segments

3.1.6. Action Points and Recommendation for Suppliers

3.2. Key Trends Impacting the Market

3.3. Formulation and Product Development Trends

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-14295

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The cleanroom technologies market growth study conducted by Future Market Insights is projected to expand at a CAGR of 6% to US$ 13.29 Bn by 2032, up from US$ 7 Bn in 2021. The rising demands for sterilized pharmaceutical formulations and the growing demand for medical device cleanrooms are driving this cleanroom technologies market growth.

In the subsequent years, technological advancements in cleanroom technology and rising demand for cleanroom technologies in developing economies are likely to provide significant cleanroom technologies market potential possibilities.

The study finds that cleanroom technologies market constraints associated with their operational expenses and the technical problems associated with modifying cleanroom designs in developing economies are hampering the cleanroom technologies market growth.

ISO 6 cleanrooms and ISO 8 cleanrooms have different prices per square foot. This is due to the fact that the volume of air delivered in both types of cleanrooms differs. In an ISO 6 cleanroom, the air is 100 times cleaner than in an ISO 8 cleanroom, increasing the air conditioning capacity of the HVAC systems.

The demand to maintain an antimicrobial environment by eliminating airborne particles in these facilities increases as the number of hospitals and Ambulatory Surgery Centers (ASCs) grows due to the various perks they provide.

There are no defined cleanroom design standards for various application areas or product types. This presents several difficulties for cleanroom technologies manufacturers, as they must adhere to various designs each time. There are no requirements for environmental, product, or facility factors to be controlled in the legislation. Instead, they only give requirements that a corporation must follow after manufacturing a product in a cleanroom setting.

Consumables dominated the cleanroom technology market in 2020, accounting for the most revenue. Another critical factor attributing to the segment’s highest cleanroom technology market share is the frequent usage of consumables and high sales of cleanroom consumables, notably gloves.

Due to the particular sensitivity of processes, cleanroom technology is vital for biotechnology-based operations such as research and development, biocontamination control, pilot studies, and production facilities. Consequently, demand for cleanroom technology is anticipated to grow as the biotechnology industry grows significantly over the forecast period.

According to the report, North America dominated the cleanroom technology market, accounting for most sales of cleanroom technology.

This is due to the region’s well-established healthcare infrastructure, the presence of significant pharmaceutical and medical device cleanroom businesses on the ground, an increase in the burden of non-communicable diseases, and growth in cosmeceutical and nutraceutical awareness. Moreover, restrictive laws governing the approval of healthcare items in this region, such as the United States, have boosted demand for cleanroom technology.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-14283

Key Takeaways:

• The consumables segment leads the cleanroom technology market in 2020, accounting for 54.1% of total revenue.
• In 2020, the pharmaceutical industry segment was expected to dominate the cleanroom technology market by end-use, accounting for 40.3% of total revenue.
• Due to the increased acceptance of biotechnology commodities worldwide, the biotechnology industry segment in the cleanroom technologies market is predicted to develop at the fastest rate of 7.2% over the forecast period.
• The equipment segment held a dominant position in the cleanroom technologies market in 2019, accounting for 74.2% share in terms of value.
• North America held the largest cleanroom technology market share in 2020, accounting for 35.5% of total revenue.

Competitive Landscape:

The cleanroom technology market is highly fragmented, with more regional competitors than cleanroom technology market manufacturers present. Mergers and acquisitions, as well as R&D relating to modular cleanroom systems’ developments, are some of the major strategies used by leading firms to grow their cleanroom technology market share.

The major cleanroom technology market manufacturers covered in the cleanroom technology market report are Simplex Isolation Systems, AES Clean Technology, DuPont, Clean Air Products, Clean Room Depot, Inc., Integrated Cleanroom Technologies Private Limited, Hemair, AIRTECH JAPAN, Ltd., Lennox International Inc., COLANDIS GMBH, ABN Cleanroom Technology, Nicos Group, Inc., Galvani S.r.l., ANSELL LTD., Ardmac, Azbil Corporation, novum. Reinraumtechnik, Helapet Ltd., KCWW, Camfil, Labconco, Taikisha Ltd, Terra Universal. Inc. and Lindner Group, among other domestic and universal cleanroom technologies market manufacturers.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-14283

Key Segments

By Product Type:

• Equipment
• Fan Filter Unit (FFU)
• HVAC Systems
• Laminar Air Flow Systems and Biosafety Cabinets
• HEPA Filters
• Air Diffusers and Showers
• Safety Consumables
• Cleaning Consumables

By End User:

• Pharmaceuticals Industry
• Biotechnology Industry
• Medical Device Manufacturer
• Hospitals

By Construction Type:

• Standard/Drywall Cleanroom
• Hardwall Cleanroom
• Softwall Cleanrooms
• Terminal Boxes

By Region:

• North America
• Latin America
• Europe
• Asia-Pacific
• Middle East & Africa

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-14283

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to a recent lateral flow assays market demand report by Future Market Insights (FMI), the lateral flow assays market was valued at US$ 11 Bn in 2021, is projected to reach US$ 12.5 Bn by 2026, and is anticipated to grow at a CAGR of around 2% over the projected period of 2022-2032.

The high rate of infectious diseases around the world, explosive growth in the geriatric population, escalating demand for point-of-care testing, and increased use of home-based rapid lateral flow devices are all boosting lateral flow assays market forward. The significant restraints are doctors’ and patients’ reluctance to change existing diagnostic techniques and the low accuracy of lateral flow assays.

The affordable cost of lateral flow assays devices and the fact that no trained personnel is required to run the tests are two factors driving up demand for lateral flow assays-based devices for COVID-19 testing. The growing adoption of kits & reagents due to innovations and benefits of lateral flow assays rapid tests over laboratory tests the high number of lateral flow assay rapid detection kits launched by healthcare companies, predominantly for lateral flow assay COVID-19 testing, are all factors contributing to the large share of the kits & reagents segment. Sandwich assays have a considerable part of the lateral flow assays market due to the growing use of sandwich assays in medical testing and the benefits of sandwich assays.

Despite the fact that lateral flow assay tests are simple to implement and less affordable than laboratory testing, they are less reliable. Due to the apparently limited accuracy of the lateral flow assay kit, most doctors and patients prefer molecular studies to fast tests for more accurate COVID-19 diagnosis. As a result, major diagnostic lateral flow assays market participants are concentrating their efforts on developing more laboratory-based infectious disease testing solutions.

Infectious disease lateral flow assays diagnostics, cardiac disease diagnosis, and veterinary applications are typical applications for lateral flow tests. However, the use of lateral flow technology has grown in various new applications in recent years. Potential applications for lateral flow tests include saliva diagnostics, behavioural health, agriculture (crop quality testing), biowarfare (anthrax detection), environmental testing, and food microbiology. Lateral flow assay (immunochromatography tests/lateral flow immunoassays) technologies continue to dominate the point of care diagnostic market through 2024. The acquisition and validation of vital reagents are one of the most challenging elements of producing lateral flow assay tests. Antibodies used in assays must be evaluated for accuracy, specificity, stability, and reproducibility, as any reagent flaws can cause the lateral flow assay to fail. Another obstacle is lateral flow assays diagnostics after an antibody or antibody pair has been found.

Key Takeaways

• The Kits & Reagents segment is anticipated to grow at a rapid CAGR of 5.3% during the forecast period.
• The clinical testing segment accounted for 90.9% of the lateral flow tests market.
• With a lateral flow tests market share of 70.9% in 2020, sandwich assays dominated the lateral flow tests market.
• Blood samples were the most preferred, with a 53.1% lateral flow tests market share.
• The hospitals and clinics segment was the most favoured, with a lateral flow tests market share of 37.6%.
• China, the world’s second-largest economy, is expected to reach a lateral flow tests market size of US$917 million in 2027, with an annual growth rate of 8.8%.
• Within Europe, Germany is expected to show a lateral flow tests market growth at a 4.8% compound annual growth rate (CAGR), while the rest of the European market will reach US$917 million by 2027.
• The Asia Pacific region is expected to increase at a CAGR of 4.2% during the forecast period.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-14271

Competitive Landscape

Some companies have increased their lateral flow tests market share through various strategies such as mergers and acquisitions. In contrast, others invent new diagnostic market test methods and provide innovative goods to maintain their market share.

Key Segments

By Application:

• Clinical Testing
• Veterinary Diagnostics
• Food Safety & Environmental Testing
• Drug Development & Quality Testing

By Technique:

• Sandwich Assays
• Competitive Assays
• Multiplex Detection Assays

By Sample Type:

• Blood Samples
• Urine Samples
• Saliva Samples
• Others
• By Type
• Kits & Reagents
• Lateral Flow Readers

By End User:

• Hospitals & Clinics
• Diagnostics Laboratories
• Home Care Settings
• Pharmaceuticals & Biotechnology Companies
• Others

By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East and Africa

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-14271

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Summary of Statistics

1.3. Key Market Characteristics & Attributes

1.4. Fact.MR Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

3.1. Risk Assessment

3.1.1. COVID-19 Crisis and Impact on Lateral Flow Assays Demand

3.1.2. COVID-19 Impact Benchmark with Previous Crisis

3.1.3. Impact on Market Value (US$ Mn)

3.1.4. Assessment by Key Countries

3.1.5. Assessment by Key Market Segments

3.1.6. Action Points and Recommendation for Suppliers

3.2. Key Trends Impacting the Market

3.3. Formulation and Product Development Trends

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-14271

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global demand for drug discovery services market Size is expected to rise at a 14.5% CAGR to acquire a valuation of US$ 50.9 Bn by the end of forecast period 2022-232. The global drug discovery services market size was valued at US$ 15.5 Bn in 2021 and is projected to reach a valuation of US$ 32 Bn by 2026

The global drug research services industry is booming as a result of increased funding for research and innovation in a multitude of segments. The drug discovery process is a significant part of the pharmaceutical sector. The study on drug discovery services market finds that the efforts of researchers towards the development of new drug prototypes have popularized outsourcing of drug discovery services. Moreover, growing spending on research and the development of novel medications for the treatment of deadly diseases and disorders has stimulated the demand for drug discovery platform. Pharmaceutical and biopharmaceutical businesses are opting for seamlessly engaged and multifunctional solution providers for drug discovery research, from the developing phase to the late testing stages. Emerging trends in drug discovery services market portends that pharmaceutical companies opt for outsourcing as a key choice to offset the shortage of in-house manpower required for new product development, as pharmaceutical businesses face great pressure to reduce overhead costs.

Restrictive laws regulating drug research and animal testing are projected to limit drug distribution to some extent. Drug discovery service organizations are facing restrictions due to a limitation of trained employees. The use of animals in pharmaceutical research is governed by strict laws. Mice, rats, fish, amphibians, and reptiles are the most common animals utilized in scientific studies. Considerations over the ethical use of animal experimentation have prompted countries to enact animal safety and use statutes, which raises a number of impediments to the future of drug discovery services market.

The drug discovery trends indicate that Biologics, such as proteins, peptides, and monoclonal antibodies, account for more than half of the therapeutic possibilities in the initial cycle. In 2022, biologics are estimated to make up for approximately half of the income earned by the top 100 pharmaceutical drugs. As per the global market study on drug discovery services, they provide the drug discovery services market with highest growth potential through the forecast period.

Despite the fact that small-molecule pharmaceutical companies monopolize the global pharmaceutical market, players working with biologics, biosimilars, and large-molecule drugs are tapping into the drug discovery services market opportunities primarily to introduce new biologic-based treatments and rising revenue from current biologics.

All-in-all, the drug discovery services market is expected to reach a valuation of US$ 32 Bn by 2026.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-14258

Key Takeaways

• The drug discovery services market is divided into two types–chemistry and biology services. In 2020, the chemistry drug discovery services category held the greatest proportion of the market.
• Small molecules are expected to occupy the largest share of revenue when compared to biologics. Drug discovery statistics specify that small molecules are expected to generate more than US$ 10,800 million in revenue by the end of 2026.
• The oncology category is predicted to have the leading position, owing to the increasing number of cancer patients around the world.
• In comparison to other innovative drug discovery services, Hit-To-Lead identification is expected to acquire the most traction.
• As the most revenue generating phase, several CROs are already delivering Hit-to-lead identification services to pharmaceutical corporations.

“The Asia Pacific drug discovery services market growth is anticipated to be the highest during the projected duration, owing to expansions happening in the pharmaceutical and biopharmaceutical industry. A high proportion of contract research organizations (CROs), government incentives, high research and development in pharmaceutical industry, and the involvement of less restrictive standards for drug discovery programs (particularly in terms of using animals for research) across several APAC countries are some drivers sustaining the healthy growth of the drug discovery services market.”, opines a seasoned FMI analyst.

Competitive Landscape

The COVID-19 pandemic highlighted the importance of outsourcing drug discovery services for companies and research groups in North America. These companies are now working together with the government to facilitate the drug discovery process.

• Existencia, a business using artificial intelligence in drug discovery, announced a collaboration with Diamond Light Source and Scripps Research on March 31, 2020, to identify COVID-19 antiviral treatments.
• Samsung Biologics, a South Korean pharmaceutical business, has signed a long-term partnership with Eli Lilly and Company to develop bamlanivimab, an investigational COVID-19 virus-neutralizing antibody.

Genesis Therapeutics and Genentech announced a multi-target drug discovery AI partnership in November 2020. Genesis’ graph machine learning and drug discovery skills will be used in this cooperation to identify novel drug candidates for therapeutic targets in a variety of illness domains.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-14258

Key Segment

By Process:

• Target Selection
• Target Validation
• Hit-to-Lead Identification
• Lead Optimization
• Candidate Validation

By Type:

• Chemistry Services
• Biology Services

By Drug Type:

• Small Molecules Drugs
• Biologics Drugs

By Therapeutic Area:

• Neurology
• Infectious and Immune System Diseases
• Digestive System Diseases
• Oncology
• Other Therapeutic Area

By End User:

• Pharmaceutical & Biotechnology Companies
• Academic Institutes
• Manufacturing
• Other End Users

By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East and Africa

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-14258

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to a recent study by Future Market Insights (FMI), the cold disposable biopsy forceps market trends is expected to witness high growth during the forecast period. The market value is slated to increase from US$ 505.1 Mn in 2020 to over US$ 1.2 Bn by 2031 at 8.4% CAGR over the forecast period (2021-2031).

The cold disposable biopsy forceps market will register high demand due the rising prevalence bronchitis and gastrointestinal disorders such as IBD and GERD among the geriatric population and the increasing awareness towards endoscopic procedures. There is also a rise in the adoption of disposable biopsy forceps that to be reliable for test sampling expects to gain popularity.

At present, the minimally-invasive technology, with the endoscope system at the core, has been extended to obstetrics, general surgery, otolaryngology, gynecology, thoracic surgery, urology, pediatrics, and other departments. Minimally-invasive endoscopic technology has become an indispensable technology for the diagnosis and treatment of chronic diseases associated with breathing, digestion, urology, otolaryngology, and so on.

With the rising demand for endoscopic minimally-invasive technology and continuous improvement in endoscopic processing technology, endoscopic applications have become prominent in almost all departments. The growing demand for diagnosis and endoscopic treatment is expected to further boost the demand for cold disposable biopsy forceps.

Numerous recent technological advances are becoming available to endoscopists. An abundance of new imaging modalities is expected to facilitate early detection of chronic disorders and other pathological entities. Most of these techniques remain investigational and are currently in clinical trials to determine patient benefits.

Companies are expanding their product lines by manufacturing different types of products for a wide range of applications.

For instance, Micro-Tech Endoscopy is mainly engaged in the R&D, manufacturing, and sales of minimally-invasive medical devices, in line with its mission of supporting clinicians with technology and innovation.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-14240

Key Takeaways from Cold Disposable Biopsy Forceps Market Study

• Oval cup forceps gained popularity and their sales are expected to grow at a CAGR of 8.8% during the forecast period.
• 8 mm diameter have sharpened cups whch ensure superior cutting performance and lead to fewer artefacts and less bleeding. The segment is therefore expected to account for a share of 24.9% in 2021.
• 2300 mm length forceps has precise jaws, no tearing and cause small wound. The segment accounted for the highest share of 37.9% in 2021.
• Upper GI Endoscopy dominated the application segment with the highest market share of 24.9% in 2021.
• Hospitals accounted for the largest share of around 42.0% in 2021 and will remain the end user in the market.

“High prevalence of conditions such as IBD and GERD and growing demand for minimally invasive endoscopic procedures are set to boost the demand for cold disposable biopsy forceps market over the next decade,” says the Future Market Insights analyst.

Who is winning?

The key players are focusing on acquisitions and partnerships with small players and suppliers to increase their market presence. Besides this, they are adopting various strategies to expand their footprint. For instance:

iIn April 2018, Boston Scientific Corporation closed its acquisition of NxThera. The company developed a minimally-invasive therapy the Rezūm system, for patients suffering from symptomatic benign prostatic hyperplasia. With the completion of the acquisition, NxThera became a part of Boston Scientific’s urology and pelvic health business. Moreover, the manufacturers are focusing on research and development activities for developing cold disposable biopsy forceps for various research applications.

In july 2020, ChargePoint and STERIS collaborated to develop a fully validated sterile transfer solution to offer a unique and integrated solution for sterile product transfer.

Some of the leading players in the cold disposable biopsy forceps market include but are not limited to Olympus Corporation, Boston Scientific Corporation, STERIS, CONMED Corporation, Cook Medical, Micro-Tech Endoscopy, Anrei Medical and other companies.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-14240

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global cold disposable biopsy forceps market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The cold disposable biopsy forceps market is segmented into six parts based on product (oval cup, oval cup with needle, alligator jaw, alligator jaw with needle) based on diameter (1.2mm, 1.8mm, 2.0mm, 2.4mm, 2.8mm, 3.7mm) based on length (1150 mm, 1550 mm, 2300 mm), based on application (enteroscopy, upper GI endoscopy, lower GI endoscopy, bronchoscopy and others, based on end user (hospitals, ambulatory surgical centers specialty clinics, diagnostic laboratories, and cancer research institutes) and across seven major regions.

Read Related Reports:

https://akastars.com/post/250074_insulin-delivery-pens-market-size-share-analysis-industry-report-trends-competit.html

https://lyfepal.com/posts/82602

https://priti-nag.tribe.so/post/insulin-delivery-pens-market-to-witness-comprehensive-growth-by-2032-the-gl–6333f5417a00bd2290fb8837

https://webyourself.eu/posts/40284

https://www.rolonet.com/posts/129125

https://community.wongcw.com/posts/193482

https://kaalama.org/read-blog/182382

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to a recent Future Market Insights (FMI) industry analysis, the demand in the high-end cellomics market share is expected to top US$ 288.8 Mn in 2021, growing at a CAGR of 6.4% during the forecast period 2021-2031.

High-end cellomics is a process that is utilized in drug discovery and biological research to identify substances such as small molecules, RNAi or peptides which alter the phenotype of a cell in a wanted manner.

The global high-end cellomics market is primarily driven by increasing technological advancement in imaging solutions. Technological advancements such as the usage of polarization methods, multicolored fluorescence-based reagents, automated imaging technology, and flow cytometry are also anticipated to boost the market growth further.

Increasing investment in research and development in cellular science of novel molecules by private and government organizations, technological advancement in imaging solutions, and advantages related to these innovations such as improved scope for pplication in gene documentation & neonatal development learning will drive the high-end cellomics market.

Key Takeaways from High-end Cellomics Market Study

• The global high-end cellomics market is expected to reach US$ 536.9 Mn by 2031.
• By application, drug discovery accounted for 55.5% of overall sales in 2021 and is expected to continue to grow at the same trend during the forecast period.
• By end-users, pharmaceutical and biotechnology companies will account for the largest share of 51.8% during the forecast period.
• By region, North America held the largest share of 32.7% of the global high-end cellomics market.
• By country, the U.S. is the most lucrative market in the global high-end cellomics market with US$ 81.7 Mn revenue in 2021.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-14164

Who is Winning?

Some of the leading manufacturers of high-end cellomics are focusing on product approvals and launch strategies for global expansion objectives, thereby, enhancing their market presence. The leading key players are focusing on strategic alliance to expand the product offerings.

Yokogawa Electronic Corporation in December 2020, agreed with InSphero AG to jointly promote the use of Yokogawa’s high-end cellomics systems for drug discovery research which actively involves the use of 3D in vitro models.

The key market players covered by FMI include PerkinElmer, Inc., ThermoFisher Scientific, Inc., Molecular Devices LLC (part of Danaher Corporation) and Yokogawa Electric Corporation.

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

High-end Cellomics Market by Category

Application:

• Academic Research/Basic Research
• Drug Discovery
  • Primary & Secondary Screening
  • Target Identification & Validation
  • Invitro Toxicity Studies
  • Compound Profiling

End-User:

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Independent Contract Research Organizations (CROs)

Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-14164

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusion & Exclusion

3. Key Trends

3.1. Key Trends Impacting the Market

3.2. Trends in Diverse Application

4. Key Success Factors

4.1. Key Products USP Analysis

4.2. Key Manufacturers Promotional Strategies

4.3. Value Chain Analysis

4.4. PESTLE Analysis

4.5. PORTERS Analysis

4.6. Key Regulations

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-14164

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to a latest study by Future Market Insights (FMI), global needle-free injectors market size  are expected to reach US$ 12.3 Bn in 2021, surging at 11.9% CAGR during the forecast period (2021-2031).

Needle-free injection is an innovative drug delivery technology that drives drugs to the skin using force which virtually nullifies the use of hypodermic needle. With growing preference for non-invasive drug delivery system and vaccines, adoption of needle-free injectors is expected to improve over the coming years

Application of needle-free injectors is increasing with rising incidence of diabetes and other chronic diseases across the globe. With increasing number of surgeries, demand for minimally invasive procedures is accelerating the sales of needle-free injectors.

According to Centers for Disease Control and Prevention (CDC), more than 51% of adults in U.S. had at least 1 chronic condition, and 27.2% had multiple chronic conditions in 2018.

Other factors driving the global demand are cost-effectiveness and safety related to needle-free injectors.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-13960

Key Takeaways from Needle-free Injectors Market study

• By load type, liquid injections segment will hold around 88.0% of value share globally.
• Based on the technology, spring-loaded jet injector is dominating the market, with over 48.0% of the market share.
• Based on the delivery site, intra dermal injector is expected to hold over 33% of the market share.
• Application of drug delivery will spur the sales of needle-free injectors, with the segment accounting for 65% of the market share.
• Based on the usage, reusable needle free injectors are highly sought-after, contributing over 78% of the market revenue.
• Hospitals are expected to be the primary end-users, holding a market share of 28% during the forecast period.
• By region, North America will dominate the global needle-free injectors market, holding 42% of total market share.
• Europe is expected to be the second-largest market, with Germany spearheading the market growth .
• India will emerge as the most lucrative market across South Asia, accounting for nearly 50% of market share in 2021.
• China will hold leading position in East Asia and is expected to account for nearly 46% of market share.

“Growing prevalence of chronic diseases coupled with rising preference of non-invasive drug delivery system will improve the adoption of needle-free injectors. With rising demand for needle-free injectors, key players are introducing new product launches and are aiming for fast track approvals to capitalize on existing opportunities and sustain their position in the industry “says the FMI Analyst.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-13960

Who is Winning?

New product launches and approvals, agreements, and collaborations are some of the key growth strategy adopted by the key players. By focusing on these strategies, key players intend to expand their global presence and strengthen their existing product portfolio.

For instance,

• In November 2019, Antares Pharma collaborated with Idorsia for the development of a novel self-administered drug-device product.
• In June 2020, Vitaeris Inc., a biotech company was acquired by CSL Limited. The acquisition was carried out by CSL Limited to achieve the motive of addressing the unmet needs of patients.

The key market players covered by FMI include Pfizer, Inc., Gerresheimer AG, Ferring Pharmaceuticals, CSL Limited (Seqirus UK Limited) and others.

Read Related Reports:

https://addandclick.com/post/268732_insulin-delivery-pens-market-forecast-2032-size-share-growth-amp-forecast-future.html

https://www.articlesfactory.com/my/articles/36a368e9-be8b-4a50-8ab1-3c81848697a9

https://figma-bosnia.tribe.so/post/insulin-delivery-pens-market-challenges-impacting-the-growth-2032-the-globa–6333f53657cc1e0fc48388b5

https://club.vexanium.com/post/insulin-delivery-pens-market-share-size-revenue-and-growth-rate-till-2032-t–6333f5d19dd9fc65b6c8232e

https://www.snipesocial.co.uk/posts/133346

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to a recent study by Future Market Insights (FMI), the global Bioprocess Technology Market Overview was valued at US$ 17.3 Bn in 2020 and is expected to register a CAGR of 15.2% during the forecast period (2021-2031). It is projected to generate a revenue of US$ 81.2 Bn by the end of 2031.

Technology has always been at the heart of biotech. The emergence of advanced computing technology such as machine learning and artificial intelligence has enabled companies to expand the scale of their research and improve efficiency in the manufacturing process—both of which reduce the time it takes for biotech firms to bring new products to market.

Increasing research and development spending on pharmaceutical products has improved the well-being of patients to a significant level. Today vaccines have proven to be one of the most effective ways to prevent children from infectious diseases. This is highly possible due to increased government spending on research & development in the life science stream.

For instance, in May 2020, AbSci Inc. closed USD 15.4 Mn in series D funding to accelerate the growth and scale of disruptive protein printing technology, by announcing an exclusive co-marketing partnership with KBI Biopharma.

There are currently more than 1,500 biomolecules undergoing clinical trials, which target more than 100 hundred types of diseases and success rate for biologics has so far been over twice that of small-molecule products.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-13890

Key Takeaways from Bioprocess Technology Market Study

• In 2021, the BIOTECH/BIOPHARMACEUTICAL COMPANIES segment is expected to dominate the global bioprocess technology market with a 44.0% market share, whereas, CDMO/contract research organization segment is expected to occupy over 40% of the market share.
• By product, the upstream segment dominated the global Bioprocess Technology Market with a 64.8% market share.
• Europe and East Asia dominated the global Bioprocess Technology Market occupying over 24.3% and 14.7% market share, respectively.

Who is winning?

Some of the leading companies of Bioprocess Technology Market are focusing on their extensive portfolio of single-use cell culture bioreactors, containers, strong distribution channels, and strategic selling to the leading biopharmaceutical manufacturing entities.

• Thermo Fisher Scientific Inc. is a multinational biotech company that develops, manufactures, and distributes products in the areas of healthcare & diagnostics, life sciences, pharmaceuticals, and others. In Sep 2020, Thermo Fisher Scientific Inc. announced the opening of its new Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri.
• Sartorius AG is a leading provider of contract testing services to the global biotechnology and biopharmaceutical industries. In July 2020, Sartorius Stedim Biotech acquired a majority stake in CellGenix to strengthen its product portfolio for cell and gene therapies.
• Danaher Corporation designs manufacture and markets professional, medical, industrial, and commercial products and services. In March 2020 Danaher Corporation acquired the Biopharma business from General Electric’s Life Sciences division.

The key market players covered by FMI include Thermo Fisher Scientific Inc, Sartorius, Merck KGa, Danaher Corporation, Applikon Biotechnology B.V., Lonza AG, Bio-Rad Laboratories, Agilent technologies, Solida Biotech GmBH, and Waters Corporation.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-13890

Key Segments:

Product:

• Upstream Equipment
  • Cell culture development products
    • Cell line development products
    • Cell Lines
    • Media, Sera and other additives
    • Cell line development kits
• Lab-scale Bioreactors
  • Continuous Stirred Tank Bioreactors
  • Bubble Column Bioreactors
  • Airlift Bioreactors
  • Fluidized Bed Bioreactors
  • Packed Bed Bioreactors
  • Photo-Bioreactors
• Scale-up and production products
  • Cell culture media and feeds
  • BioProcess Containers & Fluid Transfer Solutions

1. Single-use
2. Reusable

• • BioReactors

1. Single-Use Bioprocess Equipment
2. Continuous Bioprocess Equipment
3. Real-Time Bioprocess Equipment

• • Harvest and collection

• • • Harvest and separation products
    • Centrifuges for bioprocessing
    • Storage & Transport Products
      v. Production Tanks and Drums
      v. Outer Support Containers
• Testing Products
  • Cell Counters & Viability Analysis Systems
  • Contamination & impurity testing products
• Probes and Accessories
• Downstream Equipment
  • Downstream purification
    • Chromatography Instruments
    • Chromatography Columns
    • Others (Resins and accessories)
  • Buffer preparation and supply
    • Reagents
    • mixing systems
• Process analytical testing
  • Host cell residual DNA quantitation
  • Protein quantitation
  • Microbial identification
  • Others
• Probes and Accessories

End-User:

• Biotech / Biopharmaceutical Companies
• CDMO / Contract Research Organization
• Research / Academic Institutes

Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-13890

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global automotive brake systems market is expected to witness a rise of 3% CAGR between the forecast years of 2020-2030. The market is poised to take a hit as COVID-19 disrupts automobile production. Furthermore, economic downturn will also hamper the market in a negative manner in the coming days. Despite the gloomy picture, the global market for automotive brake systems will recover as the world limps back to normalcy by 2021. In the decade long prediction, the demand for automotive brake systems is projected to rise as road safety features will gain prominence amongst manufacturers and producers.

The demand for automotive brake systems is expected to reach US$ 6,113.2 Million in 2022, rising at a CAGR of 16.9% to US$ 29,548.6 Million from 2022 to 2032. Consumer expenditure on cars and rising consumer demand are both factors in growth. A CAGR of 7.5% was recorded for the market for automotive brake systems from 2016 to 2021.

Prominence of Road Safety to Boost Automotive Brake Systems Market

Development of the smart braking systems in automotive brake system market resulted in decreasing number of accidents. The latest advancements prevents the vehicle from skidding minimizing the risk of accidents. Rapid increase in the production and sales of vehicles coupled with stringent regulations regarding stopping distances are anticipated to magnanimously contribute to the growth of the market. Growing demand for installation of passive and active safety in vehicles is expected to trend in automotive brake system market.

Growing concern over road traffic crashes and increasing number of deaths have influenced the key players to integrate robust safety features. Stringent safety regulations by regulatory bodies and governments will continue to drive the growth of automotive brake system market. NHTSA (National Highway Traffic Safety Administration), agency of U.S. DOT (Department of Transportation) has planned to mandate adoption of Automatic Emergency Braking System (AEB) from 2022.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-503

ABS Stands Out as Some Make it a Mandate to Sell Vehicles

The global automotive brake systems market is segmented into system type, vehicle type, and system technology. The system type segment includes disc brake and drum brake. Out of these, the disc brake segment is expected to expand at a rapid pace due to better performance and heat dissipation features. In the coming years, passenger cars will lead the vehicle type segment as automotive sector shows promise of revival as economy inches closes to normalcy. The system technology segment includes traction control system (TCS), antilock braking system (ABS), electronic brake-force distribution (EBD), and electronic stability control (ESC). ABS is projected to dominate as it in mandated in several vehicles.

Asia Pacific Remains in the Lead with Shifting Focus on India

Asia Pacific is projected to control on the global automotive brake system market with growing number of consumers and manufacturers. The key countries in the mentioned region are projected to be India, South Korea, and China as an outcome of the increasing demand for commercial vehicles and passenger cars. Japan also contributes to the global automotive brake system market remarkably. While China was anticipated to be the largest opportunity in terms of revenue of the industry, the recent pandemic is expected to shift focus to India. Europe is expected to be the second largest market in global automotive brake system market followed by North America.

Key Players

Some of the key players operating in the global automotive brake system market are TRW Automotive Holdings Corp., Aisin-Seiki Co. Ltd., Continental AG, Akebono Brake Industry Co. Ltd., Brembo S.P.A., Halla Mando Corp., and others.

Key Segments Profiled in the Automotive Brake System Industry Survey

Automotive Brake System Market by System Type:

• Disc Brake in Automotive Brake System
• Drum Brake in Automotive Brake System

Automotive Brake System Market by Vehicle Type:

• Automotive Brake System in Mid-Sized Passenger Cars
• Automotive Brake System in Compact Passenger Cars
• Automotive Brake System in Luxury Passenger Cars
• Automotive Brake System in Light Commercial Vehicles
• Automotive Brake System in Heavy Commercial Vehicles
• Automotive Brake System in Premium Passenger Cars

Automotive Brake System Market by Technology:

• Anti-Lock Braking System (ABS)
• Electronic Stability Control (ESC)
• Traction Control System (TCS)
• Electronic Brake-Force Distribution (EBD)

Automotive Brake System Market by Region:

• North America Automotive Brake System Market
• Latin America Automotive Brake System Market
• Europe Automotive Brake System Market
• Asia Pacific Automotive Brake System Market
• Middle East and Africa Automotive Brake System Market

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-503

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
  • Detailed insights of market segments and sub-segments for historical as well as forecast period
  • A competitive analysis of prominent players and emerging players in the keyword market
  • Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Top Reports Related To Automotive Market Insights

Automotive Garage Equipment Market : are slated to reach US$ 24.4 Bn in 2022. Increasing replacement and repair services in used cars are expected to boost sales at a steady 4.3% CAGR, pushing the market size to US$ 32.9 Bn in 2029.

Global Automotive Interior Ambient Lighting System Market : to grow with a year-on-year growth of 4.1% in terms of value in 2022 reaching a value of about US$ 3,066.0 Mn by 2022 end. The global business is anticipated to witness a considerable CAGR of 5.4% by value during the period of 2022 and 2030.

Automotive Composites Market : was valued at US$ 8.17 Bn in 2021 and is expected to reach US$ 12.35 Bn by 2029, registering a CAGR of over 5.30% during the forecast period (2022-2029).

Automotive Active Roll Control System Market : are expected to record a steady CAGR of 4%, reaching a valuation of US$ 4.5 Bn during the forecast period of 2022-2032.

Automotive Structural Steel Market : was valued at US$ 120.49 Billion in 2022 and is expected to grow at a CAGR of 3.5% in terms of revenue between 2022 and 2032, reaching US$ 169.97 Billion by 2032.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs